M Dal Fante studies how to make bowel preparation for colonoscopies easier for patients. Specifically, they compare different cleansing solutions and regimens to see which methods lead to better results without causing too much discomfort or inconvenience. For instance, they researched two approaches: one that uses a smaller amount of a cleansing solution combined with laxative tablets and another that involves a larger quantity of solution taken in two doses. The goal is to find ways to help patients prepare for their procedures while minimizing the impact on their daily lives.
Key findings
The smaller cleansing solution (2-L PEG-citrate-simethicone) achieved a bowel cleansing success rate of 89.7%, similar to the 92.1% success of the larger solution (4-L PEG).
Visibility of the colon for examination was better with the smaller solution, scoring 85.7% compared to 72.4% for the larger solution.
Patients using the smaller solution experienced less disruption to their normal daily activities before the colonoscopy.
Frequently asked questions
Does Dr. Dal Fante study colonoscopy preparation?
Yes, Dr. Dal Fante focuses on methods to improve bowel preparation for colonoscopies.
What methods has Dr. Dal Fante researched for colonoscopy prep?
Dr. Dal Fante has researched both a smaller volume cleansing solution combined with laxative tablets and a larger volume solution taken in two doses.
Is Dr. Dal Fante's work relevant to patients preparing for colonoscopies?
Yes, their work is specifically aimed at helping patients prepare for colonoscopies in a more comfortable and effective way.
Publications in plain English
Plasma miRNA-based signatures in CRC screening programs.
2020
International journal of cancer
Zanutto S, Ciniselli CM, Belfiore A, Lecchi M, Masci E +25 more
Plain English This study looked at using tiny molecules called microRNAs found in blood to improve screening for colorectal cancer (CRC). Researchers tested blood samples from people with positive fecal tests and identified specific microRNA patterns that could indicate the presence of early-stage cancer or precursors. These blood-based tests showed promising accuracy, with areas under the curve ranging from 0.644 to 0.682 for detecting different types of lesions, which could help target colonoscopy procedures to those who need them most.
Who this helps: This benefits patients by providing a less invasive screening option and helps doctors identify those who are at higher risk for colorectal cancer.
Prevalence and features of peripheral neuropathy in Parkinson's disease patients under different therapeutic regimens.
2014
Parkinsonism & related disorders
Mancini F, Comi C, Oggioni GD, Pacchetti C, Calandrella D +8 more
Plain English This study looked at how common peripheral neuropathy (a condition that can cause weakness, numbness, and pain) is in Parkinson's disease patients on different treatments. They examined 150 patients: 50 on continuous intestinal levodopa, 50 on oral levodopa, and 50 on other drugs. They found that 28% of those on continuous levodopa had peripheral neuropathy compared to 20% on oral levodopa and just 6% on other treatments, indicating a possible link between levodopa use and this condition.
Who this helps: This research helps patients with Parkinson's disease and their doctors by highlighting the risks of peripheral neuropathy associated with levodopa treatments.
Same-day 2-L PEG-citrate-simethicone plus bisacodyl vs split 4-L PEG: Bowel cleansing for late-morning colonoscopy.
2013
World journal of gastrointestinal endoscopy
de Leone A, Tamayo D, Fiori G, Ravizza D, Trovato C +4 more
Plain English The study looked at two methods of preparing for a late-morning colonoscopy: one involved taking a smaller amount of a cleansing solution (2-L PEG-citrate-simethicone) with additional tablets, while the other used a larger amount (4-L PEG) taken in two doses. Both methods were found to be equally effective for cleaning the bowels, with 89.7% success for the smaller solution and 92.1% for the larger one, and the visibility of the colon during examination was better with the smaller solution (85.7% vs. 72.4%). This research matters because it shows that a less burdensome preparation can still work well, allowing patients to maintain their normal activities before the procedure.
Who this helps: Patients preparing for colonoscopies.
Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome.
2007
Movement disorders : official journal of the Movement Disorder Society
Antonini A, Isaias IU, Canesi M, Zibetti M, Mancini F +4 more
Plain English This study looked at how a continuous infusion of levodopa through a feeding tube affects patients with advanced Parkinson's disease over a year. Researchers found that patients experienced less time stuck in "off" periods and had fewer episodes of troublesome involuntary movements. Specifically, they saw significant improvements in daily activities and motor complications, which is important for enhancing patients' quality of life.
Who this helps: This benefits patients with advanced Parkinson's disease who struggle with severe motor fluctuations and movement issues.
Conservative management of esophageal leaks by transluminal endoscopic drainage of the mediastinum or pleural space.
1996
Surgery
Infante M, Valente M, Andreani S, Catanese C, Dal Fante M +5 more
Plain English This study looked at a new way to treat leaks that happen in the chest after esophageal surgery. Researchers used a method to drain the leaks by sending a suction tube through the esophagus, which helped clear out any buildup in the chest. Out of eight patients, seven recovered after an average of 47 days; one patient sadly died from other issues. This method shows promise for treating leaks effectively and could reduce recovery time in these cases.
Who this helps: This helps patients recovering from esophageal surgery.
Endoscopic treatment of gastrointestinal tumors: indications and results of laser photocoagulation and photodynamic therapy.
1995
Seminars in surgical oncology
Spinelli P, Mancini A, Dal Fante M
Plain English This study looked at two advanced treatments, laser therapy and photodynamic therapy, for patients with hard-to-treat gastrointestinal tumors. Among 1,015 patients treated, 93% of those with upper GI tumors and 97% with lower GI tumors saw their blocked areas reopen, while 74% and 97%, respectively, reported feeling better. The treatments were generally safe, with very low rates of complications—just 3% for upper GI and 0.5% for lower GI cases.
Who this helps: This research benefits patients suffering from gastrointestinal tumors by offering effective treatment options.
Marchesini R, Pignoli E, Tomatis S, Fumagalli S, Sichirollo AE +5 more
Plain English This study looked at how light interacts with human colon tissue by measuring how much light is absorbed and scattered at different wavelengths. The researchers found that the absorption of light ranged from 47.7 to 1.0 cm-1, and the scattering ranged from 14.2 to 6.2 cm-1 as the light wavelength increased from 300 to 800 nanometers. Understanding these properties is important because they can help improve techniques like photodynamic therapy, which uses light to treat medical conditions.
Who this helps: Patients undergoing treatments for colon-related health issues.
Rectal metal stents for palliation of colorectal malignant stenosis.
1993
Bildgebung = Imaging
Spinelli P, Dal Fante M, Mancini A
Plain English This study looked at using metal stents to help patients with blocked intestines due to colorectal cancer. Out of 13 patients, 12 had successful stent placements, and 83% saw long-term relief from their symptoms, feeling no pain or discomfort. This is important because it offers a safe and effective way to alleviate blockage in patients with advanced cancer, despite some complications for a few individuals.
Who this helps: This benefits patients with colorectal cancer and their doctors by providing a minimally invasive treatment option.
Spinelli P, Dal Fante M, Cerrai FG, Jonghi-Lavarini E, Mancini A +2 more
Plain English This study looked at different endoscopic treatments for patients with advanced esophageal cancer who couldn't have surgery and were suffering from swallowing difficulties (dysphagia). It found that 75% to 89% of patients experienced improvement after various treatments, with the duration of relief lasting from 4 to 20 weeks, and the overall survival rate was about 6.2 months. These findings are important because they show that these endoscopic procedures can effectively relieve symptoms and enhance the quality of life for patients facing a difficult prognosis.
Who this helps: This helps patients with inoperable esophageal cancer.
Endoscopic treatment of upper gastrointestinal tract malignancies.
1993
Endoscopy
Spinelli P, Cerrai FG, Dal Fante M, Mancini A, Meroni E +1 more
Plain English This study looked at different endoscopic treatments for patients with cancers of the upper gastrointestinal tract that could not be surgically removed. Researchers treated 836 patients from 1978 to 1992, and found that 96% of them were able to eat and drink better after the procedures. On average, patients lived for about 6.2 months after treatment, and only 8% had complications.
Who this helps: This benefits patients with advanced upper gastrointestinal cancers who need relief from swallowing difficulties.
Self-expanding mesh stent for endoscopic palliation of rectal obstructing tumors: a preliminary report.
1992
Surgical endoscopy
Spinelli P, Dal Fante M, Mancini A
Plain English This study looked at using self-expanding mesh stents to help patients with rectal cancer who have tumors blocking their ability to poop. In four patients treated, normal bowel movements were restored without any complications. This is important because it offers a new, effective way to relieve symptoms in patients facing severe issues from their tumors.
Who this helps: This benefits patients with rectal cancer and their healthcare providers.
Current role of laser and photodynamic therapy in gastrointestinal tumors and analysis of a 10-year experience.
1992
Seminars in surgical oncology
Spinelli P, Dal Fante M, Mancini A
Plain English This study looked at how laser and photodynamic therapy can treat tumors in the gastrointestinal tract. Researchers found that laser treatment completely removed 70% of colorectal adenomas, and it helped 93% of patients with obstructive cancer feel better. For patients whose tumors could be opened up with laser treatment, one-year survival was much higher at 23% compared to just 7% for those who didn’t receive this treatment.
Who this helps: This benefits patients with gastrointestinal tumors, especially those with advanced or obstructive cancers.
Light-induced fluorescence spectroscopy of adenomas, adenocarcinomas and non-neoplastic mucosa in human colon. I. In vitro measurements.
1992
Journal of photochemistry and photobiology. B, Biology
Marchesini R, Brambilla M, Pignoli E, Bottiroli G, Croce AC +3 more
Plain English This study looked at how a technique called fluorescence spectroscopy can help tell the difference between abnormal and normal tissue in the colon by analyzing 83 biopsy samples. The researchers found that the method can accurately identify neoplastic (tumor-related) tissues with an 80.6% sensitivity and 90.5% specificity, meaning it could correctly diagnose many cases while minimizing false positives. This is important because it could lead to better and earlier detection of colon cancers during routine examinations.
Who this helps: This benefits patients undergoing colon examinations and doctors diagnosing potential cancers.
Endoscopic palliation of malignancies of the upper gastrointestinal tract using Nd:YAG laser: results and survival in 308 treated patients.
1991
Lasers in surgery and medicine
Spinelli P, Dal Fante M, Mancini A
Plain English Researchers studied how effective a specific laser treatment is for patients with blocked tumors in the upper gastrointestinal tract. They found that 94% of patients could have their esophagus opened again, while 74% improved their ability to swallow. The one-year survival rate for patients who had successful treatment was 23%, compared to just 7% for those who did not.
Who this helps: This helps patients with obstructive gastrointestinal tumors.
Small-cell carcinoma of the esophagus. Treatment by endoscopy.
1990
Surgical endoscopy
Di Felice G, Dal Fante M, Spinelli P
Plain English Researchers studied a rare type of cancer in the esophagus called small-cell carcinoma and how it can be treated using endoscopy. A patient received treatment with a special laser and a tube to help with swallowing, which improved their nutrition and quality of life. Although laser therapy is not commonly used for this type of cancer, the positive results of this case show it can be an effective option.
Who this helps: This helps cancer patients and their doctors explore new treatment options.
The use of videoendoscopy in the study of fluorescence.
1990
Endoscopy
Spinelli P, Block P, Dal Fante M
Plain English This study looked at how videoendoscopy, a technique that uses a tiny camera, improves the detection of cancer through fluorescence, which is the glow given off by certain chemicals after exposure to light. The researchers found that using electronic video-endoscopes made it easier to spot cancerous tissues compared to traditional fiberoptic endoscopes because they capture signals directly from the area being examined. This method not only enhances the visibility of cancerous cells but also allows for better image manipulation, making it clearer which tissues are healthy and which are not.
Who this helps: This benefits patients undergoing cancer diagnosis, as well as doctors who need better tools for detection.
Ultrasonography versus laparoscopy in the diagnosis of hepatic tumors.
1984
The Italian journal of surgical sciences
Spinelli P, Dal Fante M, Garbagnati F, Masciadri N, Pizzetti P
Plain English This study looked at two methods, ultrasound and laparoscopy, to diagnose liver tumors in 129 patients. It found that ultrasound accurately diagnosed liver issues 86.7% of the time, while laparoscopy had a slightly higher accuracy of 89.4%. When both methods were used together, they identified liver lesions in 98.4% of cases, making this combined approach efficient and cost-effective, even in facilities with limited resources.
Who this helps: This benefits patients suspected of having liver tumors, as well as doctors diagnosing these conditions.
[Evaluations of 169 cases of decompression sickness treated in Italian hyperbaric centers 1980-1981].
1983
Minerva medica
Marroni A, Catalucci G, Dal Fante M, Frattini C
Plain English This study looked at 169 cases of decompression sickness, a condition that can occur during diving, in Italy from 1980 to 1981. Most of these cases (95.6%) were caused by poor planning and panic while resurfacing, rather than issues with diving equipment. The research found that 78.2% of those with type I decompression sickness and 61.9% with type II fully recovered due to hyperbaric treatment, particularly when certain recommended protocols were used.
Who this helps: This information benefits divers and medical professionals treating diving-related injuries.